Foster Dykema Cabot & CO Inc Johnson & Johnson Transaction History

Foster Dykema Cabot & CO Inc

$827 Million
Q3 2023

A detailed history of Foster Dykema Cabot & CO Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Foster Dykema Cabot & CO Inc holds 4,652 shares of JNJ stock, worth $677,238. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,652

Previous 3,919 18.7%

Holding current value

$677,238

Previous $649,000 11.71%

% of portfolio

0.09%

Previous 0.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $114,164 - $127,893	733 Added 18.7%	4,652 $725,000
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $24,168 - $28,841	160 Added 4.26%	3,919 $607,000
Q4 2022 Feb 01, 2023	SELL	$160.2 - $179.79 $691,263 - $775,793	-4,315 Reduced 53.44%	3,759 $664,000
Q3 2022 Feb 03, 2023	BUY	$161.33 - $179.52 $696,138 - $774,628	4,315 Added 114.79%	8,074 $1.32 Million
Q3 2022 Oct 20, 2022	SELL	$161.33 - $179.52 $91,151 - $101,428	-565 Reduced 6.54%	8,074 $1.32 Million
Q2 2022 Jul 15, 2022	SELL	$168.19 - $186.01 $11,941 - $13,206	-71 Reduced 0.82%	8,639 $1.53 Million
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $405,470 - $460,468	-2,564 Reduced 22.74%	8,710 $1.54 Million
Q3 2021 Oct 25, 2021	SELL	$161.5 - $179.47 $13,566 - $15,075	-84 Reduced 0.74%	11,274 $1.82 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $92,019 - $98,707	-577 Reduced 4.83%	11,358 $1.87 Million
Q1 2021 May 03, 2021	BUY	$153.07 - $170.48 $154,294 - $171,843	1,008 Added 9.22%	11,935 $1.96 Million
Q4 2020 Feb 03, 2021	SELL	$137.11 - $157.38 $139,715 - $160,370	-1,019 Reduced 8.53%	10,927 $1.72 Million
Q2 2020 Aug 05, 2020	BUY	$128.81 - $155.51 $13,782 - $16,639	107 Added 0.9%	11,946 $1.68 Million
Q4 2019 Feb 04, 2020	SELL	$127.5 - $146.44 $397,927 - $457,039	-3,121 Reduced 20.86%	11,839 $1.73 Million
Q3 2019 Nov 05, 2019	SELL	$126.95 - $142.14 $164,273 - $183,929	-1,294 Reduced 7.96%	14,960 $1.94 Million
Q2 2019 Aug 06, 2019	SELL	$131.15 - $144.24 $19,016 - $20,914	-145 Reduced 0.88%	16,254 $2.26 Million
Q4 2018 Feb 05, 2019	BUY	$122.84 - $147.84 $81,074 - $97,574	660 Added 4.19%	16,399 $2.12 Million
Q3 2018 Nov 02, 2018	SELL	$121.58 - $142.88 $101,884 - $119,733	-838 Reduced 5.06%	15,739 $2.18 Million
Q2 2018 Aug 06, 2018	SELL	$119.4 - $131.76 $104,116 - $114,894	-872 Reduced 5.0%	16,577 $2.19 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $12,009 - $14,221	-96 Reduced 0.55%	17,449 $2.24 Million
Q4 2017 Jan 31, 2018	BUY	$131.22 - $143.62 $17,583 - $19,245	134 Added 0.77%	17,545 $2.45 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $2.25 Million - $2.36 Million	17,411	17,411 $2.26 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & CO Inc with notifications on news.

Account

Foster Dykema Cabot & CO Inc Johnson & Johnson Transaction History